CoChat

Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma

Inancli, Serap Soytac, Usluogullari, Alper, Ustu, Yusuf, Caner, Sedat, Tam, Abbas Ali, Ersoy, Reyhan, Cakir, Bekir · 2013 · Endocrine

The DOI matches its Crossref record; 36 of the 38 references it cites were found in a registry or an index.

Abstract

The aim of this study was to evaluate the effect of Cabergoline on insulin sensitivity, inflammatory markers, and carotid intima media thickness in prolactinoma patients. Twenty-one female, newly diagnosed patients with prolactinoma were included in the study. None of the patients were treated previously. Cabergoline was given as treatment, starting with 0.5 mg/day and tapered necessarily. Blood samples were taken for prolactin, highly sensitive C-reactive protein, homocysteine, total cholesterol, low density lipoprotein (LDL) cholesterol, fasting glucose, insulin, and HOMA (homeostasis model assessment of insulin resistance) score was calculated, prior to and 6 months after starting treatment. The body mass index (BMI) was measured and carotid intima media thickness (CIMT) was evaluated for each patient prior to and 6 months after the treatment. The prolactin levels and LDL decreased significantly after cabergoline treatment. Insulin sensitivity improved independently from the decrease in prolactin levels and BMI. The significant decrease in homocysteine and hs-CRP was not related with the decrease in prolactin levels. The significant decrease in CIMT was independent from the decrease in prolactin levels, HOMA score, and BMI. Our data suggest that cabergoline treatment causes an improvement in insulin sensitivity and inflammatory markers and causes a decrease in CIMT independent from the decrease in prolactin, LDL cholesterol, and BMI. We conclude that short term cabergoline…

Overview

Integrity signals

Registry

Crossref · 10.1007/s12020-012-9857-y

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 36 references

Cited by

See all 59

Metadata

Authors
Inancli, S. S., Usluogullari, A., Ustu, Y., Caner, S., Tam, A. A., Ersoy, R., & Cakir, B.
Affiliations
Ankara Atatürk Eğitim ve Araştırma Hastanesi (TR)
Venue
Endocrine
Published
2012-12-12
Volume
44
Issue
1
Pages
193-199
ISSN
  • 0969-711X (ISSN-L)
  • 1355-008X
  • 1559-0100
OpenAlex
W2005558563
Cited by
59
References
38
Citations by year
2026: 6 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 3 · 2021: 5 · 2019: 6 · 2017: 2 · 2016: 5 · 2015: 3 · 2014: 6 · 2013: 6
FWCI
3.85
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Endocrine (publishedVersion)
  • PubMed (publishedVersion)
  • AYBU AVESIS (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
Keywords
cabergoline, prolactinoma, insulin sensitivity, insulin resistance, carotid intima-media thickness, endothelial function, inflammation, C-reactive protein, homocysteine, prolactin, LDL cholesterol, body mass index, dopamine agonist therapy
MeSH terms
Cabergoline, Adolescent, Adult, Ergolines, Female, Glucose Tolerance Test, Humans, Inflammation, Insulin Resistance, Middle Aged, Pituitary Neoplasms, Prolactinoma, Biomarkers, Antineoplastic Agents, Hormonal, Young Adult, Carotid Intima-Media Thickness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma. https://app.cochat.ai/papers/10.1007/s12020-012-9857-y
The paper
Inancli, S. S., Usluogullari, A., Ustu, Y., Caner, S., Tam, A. A., Ersoy, R., & Cakir, B. (2013). Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma. Endocrine. https://doi.org/10.1007/s12020-012-9857-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.